A review of the pharmacokinetics, efficacy and safety of high‐purity factor X for the prophylactic treatment of hereditary factor X deficiency

INTRODUCTION: Hereditary factor X (FX) deficiency (FXD) is a rare autosomal recessive bleeding disorder. Plasma‐derived FX (pdFX) is a high‐purity FX concentrate approved in the United States and Europe for the treatment and prophylaxis of bleeding episodes and for peri‐operative management in patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Payne, Jeanette, Batsuli, Glaivy, Leavitt, Andrew D., Mathias, Mary, McGuinn, Catherine E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541946/
https://www.ncbi.nlm.nih.gov/pubmed/35499465
http://dx.doi.org/10.1111/hae.14570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541946/
https://www.ncbi.nlm.nih.gov/pubmed/35499465
http://dx.doi.org/10.1111/hae.14570

Ejemplares similares